The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes.
about
Cellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands.Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands.Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor CellsThe induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex.Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action.Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells.Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.Studies on Photocleavage, DNA Binding, Cytotoxicity, and Docking Studies of Ruthenium(II) Mixed Ligand Complexes.The contrasting catalytic efficiency and cancer cell antiproliferative activity of stereoselective organoruthenium transfer hydrogenation catalysts.Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells.Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells.Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models.Bis(dipyridophenazine)(2-(2'-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) hexafluorophosphate: a lesson in stubbornness.A bis(dipyridophenazine)(2-(2-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) complex with anticancer action upon photodeprotection.Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells.Analysis of the cytotoxic effects of ruthenium-ketoconazole and ruthenium-clotrimazole complexes on cancer cells.A dinuclear ruthenium(II) complex as a one- and two-photon luminescent probe for biological Cu(2+) detection.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.Novel mitochondria targeted copper(ii) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity.Mitochondrial selectivity and remarkable photocytotoxicity of a ferrocenyl neodymium(III) complex of terpyridine and curcumin in cancer cells.Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation.Near-infrared emitting iridium(iii) complexes for mitochondrial imaging in living cells.Iridium(III) Anthraquinone Complexes as Two-Photon Phosphorescence Probes for Mitochondria Imaging and Tracking under Hypoxia.Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.Synthesis, characterization and biological evaluation of labile intercalative ruthenium(ii) complexes for anticancer drug screening.Supramolecular metalloglycodendrimers selectively modulate lectin binding and delivery of Ru(ii) complexes into mammalian cells.Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation.Achieving efficient photodynamic therapy under both normoxia and hypoxia using cyclometalated Ru(ii) photosensitizer through type I photochemical process.Dual inhibition of topoisomerases I and IIα by ruthenium(II) complexes containing asymmetric tridentate ligands.
P2860
Q33670035-F0BD5E99-19D5-43B7-9190-DBFEF37D03C5Q34331245-2461EEC2-DFF6-47C2-BEC5-FA8C780D3A2EQ36499563-8B346AC1-0160-4A54-880E-BD8FDDC8AF53Q37697060-1FDA6726-E890-4FCB-8603-734BA08334BBQ37724010-C2C156E4-2F82-4616-95CC-D12DA4934136Q38199383-6458653C-C19B-48DB-B36A-E0E4C9B882F2Q38401551-240C3426-B50B-4F56-BAEB-E5FF3716A2D8Q38704083-73263953-433E-415E-89CF-F9D6EE2E0CD3Q38735217-FAA7C514-4E82-48FF-821B-38B0C99D78A5Q38775808-C173C77B-29E8-4E14-A1F8-A7389606DAB0Q38838150-5EADD881-32FC-4F7F-9B6B-732B073E3D8FQ38914068-C3F1E66A-FE74-4308-9E74-57A7229AABACQ38941173-16A47277-EA33-42FE-866A-9AD9B52CD4D6Q39018867-08FE64D7-0305-490B-8723-EA8271846C5EQ39026748-BC511B4F-CEC5-4D13-98FB-AAD6EE82A42AQ39052398-1581F960-57DB-479C-8D79-F31B15252D34Q39055996-1A3F67C2-DAEB-4EDE-839D-57B3325CCAD8Q39069281-A2AEE5F0-17C8-4A16-984E-1B78BEE0F8FBQ39400527-A3BABF19-2A3E-4A80-8E59-315083BB305EQ46449120-216D1B27-BF6F-4E2A-8C11-F167C4777A1FQ46584322-B15E81AC-2CED-4A60-90C9-8FB2115C3821Q47970194-8900BE2C-ABA3-4F7A-BDA6-A7E675F82CADQ48360744-65650A1C-FD40-44C2-A5D7-D8A40A113594Q48617090-265BA024-B9E0-4E7A-A18D-E073619A191CQ50063144-5953A1EE-E471-4815-8EEB-6BCC34FA30DAQ50798904-D6BDBA6D-D3E6-45BA-80B7-9A2DDC5A5CE2Q51420976-A6BFB1EC-8C50-4ECA-BB38-B5E3762D12BAQ51820438-FE232FDC-121B-42BC-A1DA-054218BFF76AQ52606012-47628846-2B7E-453B-9B03-FD92FD08A605Q53414064-32A51A1C-6765-4195-849E-DD3E6EF8C607
P2860
The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium
@nl
The induction of mitochondria- ...... nium(II) asymmetric complexes.
@en
type
label
The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium
@nl
The induction of mitochondria- ...... nium(II) asymmetric complexes.
@en
prefLabel
The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium
@nl
The induction of mitochondria- ...... nium(II) asymmetric complexes.
@en
P2093
P2860
P356
P1433
P1476
The induction of mitochondria- ...... nium(II) asymmetric complexes.
@en
P2093
Cui-Lan Song
Jin-Quan Wang
Li-Li Wang
Liang-Nian Ji
P2860
P304
P356
10.1039/C3MT20270D
P577
2013-06-01T00:00:00Z